Latest filing published 19 Jan 2023 for Idera Pharmaceuticals, INC..
Insider track record
No signal scores available.
John Clayton Taylor: trading record in brief
John Clayton Taylor discloses dealings in Idera Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 28 September 2022 to 17 January 2023, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 19 January 2023 with an option exercise in Idera Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Clayton Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,341,764 sharesCommon StockSEC:0001104659-23-005133:0
- 2,171,214 sharesCommon Stock, par value $0.001SEC:0001104659-22-104797:0
2 of 2 declarations